Norsk forening for medisinsk mikrobiologi


Publikasjoner i 2001

19. november 2019
  1. Allunans J, Bøvre K. Unusual antineisserial activity expressed by a systemic isolate of Neisseria meningitidis. antimeningococcal effect and properties. Scand J Infect Dis 2001; 33(7):516-522.

  2. Andersen JH, Osbakk SA, Vorland LH, Traavik T, Gutteberg TJ. Lactoferrin and cyclic lactoferricin inhibit the entry of human cytomegalovirus into human fibroblasts. Antiviral Res 2001; 51(2):141-149.
  3. Antal EA, Løberg EM, Bracht P, Melby KK, Maehlen J. Evidence for intraaxonal spread of Listeria monocytogenes from the periphery to the central nervous system. Brain Pathol 2001; 11(4):432-438.

  4. Aukrust P, Berge RK, Ueland T, Aaser E, Damas JK, Wikeby L et al. Interaction between chemokines and oxidative stress: possible pathogenic role in acute coronary syndromes. J Am Coll Cardiol 2001; 37(2):485-491.
  5. Bakke H, Lie K, Haugen IL, Korsvold GE, Høiby EA, Naess LM et al. Meningococcal outer membrane vesicle vaccine given intranasally can induce immunological memory and booster responses without evidence of tolerance. Infect Immun 2001; 69(8):5010-5015.
  6. Bergan T, Klaveness J, Aasen AJ. Chelating agents. Chemotherapy 2001; 47(1):10-14.
  7. Bergan T. Antibiotic usage in Nordic countries. Int J Antimicrob Agents 2001; 18(3):279-282.
  8. Berild D, Ringertz SH, Lelek M, Fosse B. Antibiotic guidelines lead to reductions in the use and cost of antibiotics in a university hospital. Scand J Infect Dis 2001; 33(1):63-67.
  9. Berstad AE, Høgåsen K, Bukholm G, Moran AP, Brandtzaeg P. Comp lement activation directly induced by Helicobacter pylori. Gastroenterology 2001; 120(5):1108-1116.
  10. Brorson O, Brorson SH, Henriksen TH, Skogen PR, Schøyen R. Association between multiple sclerosis and cystic structures in cerebrospinal fluid. Infection 2001; 29(6):315-319.
  11. Bruland T, Dai HY, Lavik LA, Kristiansen LI, Dalen A. Gender-related differences in susceptibility, early virus dissemination and immunosuppression in mice infected with Friend murine leukaemia virus variant FIS-2. J Gen Virol 2001; 82(Pt 8):1821-1827.
  12. Bukholm IR, Bukholm G, Nesland JM. Over-expression of cyclin A is highly associated with early relapse and reduced survival in patients with primary breast carcinomas. Int J Cancer 2001; 93(2):283-287.
  13. Christensen A, Scheel O, Urwitz K, Bergh K. Outbreak of methicillin-resistant Staphylococcus aureus in a Norwegian hospital. Scand J Infect Dis 2001; 33(9):663-666.
  14. Dahle UR, Sandven P, Heldal E, Caugant DA. Molecular epidemiology of Mycobacterium tuberculosis in Norway. J Clin Microbiol 2001; 39(5):1802-1807. 
  15. Degre M, Ranneberg-Nilsen T, Beck S, Rollag H, Fiane AE. Human cytomegalovirus productively infects porcine endothelial cells in vitro. Transplantation 2001; 72(7):1334-1337.
  16. Degre M, Kristiansen KI, Rollag H, Holter E, Nordal KP. Detection of human cytomegalovirus (HCMV) pp67-mRNA and pp65 antigenemia in relation to development of clinical HCMV disease in renal transplant recipients. Clin Microbiol Infect 2001; 7(5):254-260.
  17. Dyrhol-Riise AM, Voltersvik P, Berg OG, Olofsson J, Kleivbo S, Åsjø B. Residual human immunodeficiency virus type 1 infection in lymphoid tissue during highly active antiretroviral therapy: quantitation and virus characterization. AIDS Res Hum Retroviruses 2001; 17(7):577-586.
  18. Dyrhol-Riise AM, Stent G, Røsok BI, Voltersvik P, Olofsson J, Åsjø B. The Fas/FasL system and T cell apoptosis in HIV-1-infected lymphoid tissue during highly active antiretroviral therapy. Clin Immunol 2001; 101(2):169-179.
  19. Dyrhol-Riise AM, Ohlsson M, Skarstein K, Nygaard SJ, Olofsson J, Jonsson R et al. T cell proliferation and apoptosis in HIV-1-infected lymphoid tissue: impact of highly active antiretroviral therapy. Clin Immunol 2001; 101(2):180-191.
  20. Eide L, Fosberg E, Hoff E, Seeberg E. Overexpression of endonuclease III protects Escherichia coli mutants defective in alkylation repair against lethal effects of methylmethanesulphonate. FEBS Lett 2001; 491(1-2):59-62.
  21. Fluge G, Ojeniyi B, Høiby N, Digranes A, Ciofu O, Hunstad E et al. Typing of Pseudomonas aeruginosa strains in Norwegian cystic fibrosis patients. Clin Microbiol Infect 2001; 7(5):238-243.
  22. Glad T, Klingenberg C, Flaegstad T, Ericson JU, Olsvik O. Rapid detection of the methicillin-resistance gene, mecA, in coagulase- negative Staphylococci. Scand J Infect Dis 2001; 33(7):502-506.
  23. Grewal HM, Sommerfelt H. Genotypic detection of enterotoxigenic Escherichia coli colonisation factors. APMIS 2001; 109(6):447-453.
  24. Grude N, Tveten Y, Kristiansen BE. Urinary tract infections in Norway: bacterial etiology and susceptibility. A retrospective study of clinical isolates. Clin Microbiol Infect 2001; 7(10):543-547.
  25. Haaheim H, Vorland L, Gutteberg TJ. Laboratory diagnosis of respiratory diseases: PCR versus serology. Nucleosides Nucleotides Nucleic Acids 2001; 20(4-7):1255-1258.
  26. Haukland HH, Vorland LH. Post-antibiotic effect of the antimicrobial peptide lactoferricin on Escherichia coli and Staphylococcus aureus. J Antimicrob Chemother 2001; 48(4):569-571.
  27. Haukland HH, Ulvatne H, Sandvik K, Vorland LH. The antimicrobial peptides lactoferricin B and magainin 2 cross over the bacterial cytoplasmic membrane and reside in the cytoplasm. FEBS Lett 2001; 508(3):389-393.
  28. Huang LY, Jonassen TØ, Hungnes O, Grinde B. High prevalence of TT virus-related DNA (90%) and diverse viral genotypes in Norwegian blood donors. J Med Virol 2001; 64(3):381-386.
  29. Husebye E, Hellstrom PM, Sundler F, Chen J, Midtvedt T. Influence of microbial species on small intestinal myoelectric activity and transit in germ-free rats. Am J Physiol Gastrointest Liver Physiol 2001; 280(3):G368-G380.
  30. Jeansson S, Kvien TK. Acanthamoeba polyphaga in rheumatoid arthritis: possibility for a chronic infection. Scand J Immunol 2001; 53(6):610-614.
  31. Jenkins A, Handeland K, Stuen S, Schouls L, van dP, I, Meen RT et al. Ehrlichiosis in a moose calf in Norway. J Wildl Dis 2001; 37(1):201-203.
  32. Jenkins A, Kristiansen BE, Allum AG, Aakre RK, Strand L, Kleveland EJ et al. Borrelia burgdorferi sensu lato and Ehrlichia spp. in Ixodes ticks from southern Norway. J Clin Microbiol 2001; 39(10):3666-3671.
  33. Jonassen CM, Jonassen TØ, Saif YM, Snodgrass DR, Ushijima H, Shimizu M et al. Comparison of capsid sequences from human and animal astroviruses. J Gen Virol 2001; 82(Pt 5):1061-1067.
  34. Klungland A, Paulsen R, Rolseth V, Yamada Y, Ueno Y, Wiik P et al. 5-Formyluracil and its nucleoside derivatives confer toxicity and mutagenicity to mammalian cells by interfering with normal RNA and DNA metabolism. Toxicol Lett 2001; 119(1):71-78.
  35. Kristiansen BE, Tveten Y, Vorland L, Sandnes RA, Mortensen L. The prevalence of bacterial resistance in respiratory pathogens in Norway is low. Clin Microbiol Infect 2001; 7:682-7. 
  36. Leegaard TM, Bevanger L, Jureen R, Lier T, Melby KK, Caugant DA et al. Antibiotic sensitivity still prevails in Norwegian blood culture isolates. Int J Antimicrob Agents 2001; 18(2):99-106.
  37. Lindbæk M, Melby KK, Schøyen R, Hjortdahl P. Bacteriological findings in nasopharynx specimens from patients with a clinical diagnosis of acute sinusitis. Scand J Prim Health Care 2001; 19(2):126-130.
  38. Moens U, Van Ghelue M, Kristoffersen AK, Johansen B, Rekvig OP, Degre M et al. Simian virus 40 large T-antigen, but not small T-antigen, trans- activates the human cytomegalovirus major immediate early promoter. Virus Genes 2001; 23(2):215-226.
  39. Mylvaganam H, Bjorvatn B, Osland A. Polymorphism of the virulence regulon and allelic variations of the sic gene among the emm1 isolates of group A Streptococcus from western Norway. Microb Pathog 2001; 30(2):71-79.
  40. Nordøy T, Husebekk A, Aaberge IS, Jenum PA, Samdal HH, Flugsrud LB et al. Humoral immunity to viral and bacterial antigens in lymphoma patients 4- 10 years after high-dose therapy with ABMT. Serological responses to revaccinations according to EBMT guidelines. Bone Marrow Transplant 2001; 28(7):681-687.
  41. Pettersen RJ, Muna ZA, Kuiper KK, Svendsen E, Müller F, Aukrust P et al. Sustained retention of tetradecylthioacetic acid after local delivery reduces angioplasty-induced coronary stenosis in the minipig. Cardiovasc Res 2001; 52(2):306-313.
  42. Radtke A, Bergh K, Øien CM, Bevanger LS. Peritoneal dialysis-associated peritonitis caused by Dermabacter hominis. J Clin Microbiol 2001; 39(9):3420-3421.
  43. Rognes T. ParAlign: a parallel sequence alignment algorithm for rapid and sensitive database searches. Nucleic Acids Res 2001; 29(7):1647-1652.
  44. Sandven P, Giercksky KE. Yeast colonization in surgical patients with intra-abdominal perforations. Eur J Clin Microbiol Infect Dis 2001; 20(7):475-481.
  45. Schumacher A, Lerkerod AB, Seljeflot I, Sommervoll L, Holme I, Otterstad JE et al. Chlamydia pneumoniae serology: importance of methodology in patients with coronary heart disease and healthy individuals. J Clin Microbiol 2001; 39(5):1859-1864.
  46. Skogen PG, Kolmannskog S, Bergh K. Bactericidal activity in cerebrospinal fluid by treating meningitis caused by Stomatococcus mucilaginosus with rifampicin, cefotaxime and vancomycin in a neutropenic child. Clin Microbiol Infect 2001; 7(1):39-42. 
  47. Stenfors LE, Bye HM, Vorland LH. Remarkable attachment of lactoferrin to Streptococcus pyogenes during acute pharyngotonsillitis. Acta Otolaryngol 2001; 121(5):637-642.
  48. Stylianou E, Aukrust P, Müller F, Nordøy I, Frøland SS. Complex effects of interferon-alpha on the cytokine network in HIV infection--possible contribution to immunosuppression. Cytokine 2001; 14(1):56-62.
  49. Tannaes T, Dekker N, Bukholm G, Bijlsma JJ, Appelmelk BJ. Phase variation in the Helicobacter pylori phospholipase A gene and its role in acid adaptation. Infect Immun 2001; 69(12):7334-7340.
  50. Tessema TA, Bjune G, Assefa G, Bjorvatn B. An evaluation of the diagnostic value of clinical and radiological manifestations in patients attending the addis ababa tuberculosis centre. Scand J Infect Dis 2001; 33(5):355-361.
  51. Trogstad LI, Eskild A, Bruu AL, Jeansson S, Jenum PA. Is preeclampsia an infectious disease? Acta Obstet Gynecol Scand 2001; 80(11):1036-1038.
  52. Tønjum T, Seeberg E. Microbial fitness and genome dynamics. Trends Microbiol 2001; 9(8):356-358.
  53. Ueland T, Bollerslev J, Godang K, Müller F, Frøland SS, Aukrust P. Increased serum osteoprotegerin in disorders characterized by persistent immune activation or glucocorticoid excess--possible role in bone homeostasis. Eur J Endocrinol 2001; 145(6):685-690.
  54. Ulvatne H, Vorland LH. Bactericidal kinetics of 3 lactoferricins against Staphylococcus aureus and Escherichia coli. Scand J Infect Dis 2001; 33(7):507-511.
  55. Ulvatne H, Karoliussen S, Stiberg T, Rekdal O, Svendsen JS. Short antibacterial peptides and erythromycin act synergically against Escherichia coli. J Antimicrob Chemother 2001; 48(2):203-208.
  56. Ulvatne H, Haukland HH, Olsvik O, Vorland LH. Lactoferricin B causes depolarization of the cytoplasmic membrane of Escherichia coli ATCC 25922 and fusion of negatively charged liposomes. FEBS Lett 2001; 492(1-2):62-65.
  57. Ulvestad E, Kanestrøm A, Sønsteby LJ, Jureen R, Omland T, Edvardsen B et al. Diagnostic and biological significance of anti-p41 IgM antibodies against Borrelia burgdorferi. Scand J Immunol 2001; 53(4):416-421.
  58. Vainio K, Stene-Johansen K, Jonassen TØ, Bruu AL, Grinde B. Molecular epidemiology of calicivirus infections in Norway. J Med Virol 2001; 65(2):309-314.
  59. Vainio K, Borch E, Bruu AL. No sequence variation in part of the hexon and the fibre genes of adenovirus 8 isolated from patients with conjunctivitis or epidemic keratoconjunctivitis (EKC) in Norway during 1989 to 1996. J Clin Pathol 2001; 54(7):558-561.
  60. Walberg M, Steen HB. Flow cytometric monitoring of bacterial susceptibility to antibiotics. Methods Cell Biol 2001; 64:553-566.
  61. Warris A, Gaustad P, Meis JF, Voss A, Verweij PE, Abrahamsen TG. Recovery of filamentous fungi from water in a paediatric bone marrow transplantation unit. J Hosp Infect 2001; 47(2):143-148.